Our Brands
Randox Acusera Laboratory Quality Control
Acusera Infectious Disease (Serology) Controls are designed to deliver a cost effective, high quality solution for the analysis of infectious diseases whilst producing trustworthy results time and time again. Covering a wide range of infectious diseases, including HIV, Hepatitis, EBV, ToRCH, and Lyme Disease, our controls are compatible for use on some of the most popular immunoassay platforms including Roche, Abbott, Siemens and Beckman among others.
Benefits
Liquid ready-to-use
- All samples are provided in a user-friendly, liquid ready-to-use format significantly reducing preparation time and the risk of pipetting errors
Integration with software
- Pairs with Acusera 24.7 for automated QC rules, peer group data, and ISO 15189 compliance reporting
Randox Serology QC
Randox Qnostics
Qnostics is a Randox brand specializing in third‑party molecular infectious disease quality controls for clinical and reference laboratories. Its liquid‑frozen, whole‑pathogen controls cover a wide range of viral, bacterial, and fungal targets and are designed to verify performance of nucleic acid testing workflows from extraction through detection across multiple platforms.
Benefits
- Provides true third‑party molecular controls that are independent of assay manufacturers, improving confidence in day‑to‑day performance of NAT and other molecular assays.
- Uses whole‑pathogen, inactivated, liquid‑frozen controls that assess the entire workflow from extraction to detection, improving detection of pre‑analytical and analytical issues in molecular testing.
- Covers an extensive infectious disease portfolio (respiratory, blood‑borne viruses, STI, GI, CNS, transplant, resistance markers), allowing harmonised QC across different molecular platforms and assays.
Randox EQAP
Randox Acusera Laboratory Quality Control
RIQAS (Randox International Quality Assessment Scheme) is a large external quality assessment / proficiency testing programme that helps laboratories objectively monitor and improve the accuracy of their test results across many disciplines and analytes. Participating labs receive regular EQA samples, compare their performance to extensive international peer groups, and use the scheme’s statistically based reports—supported by ISO/IEC 17043 accreditation—to meet accreditation and regulatory quality requirements
Benefits
- Provides independent external comparison against large international peer groups, helping identify systematic bias, imprecision, and method issues that internal QC alone may miss.
- Supports ISO 15189 and regulatory compliance through participation in an ISO/IEC 17043–accredited proficiency testing scheme, with structured reports that facilitate audits and corrective actions
- Offers consolidated, multi‑parameter EQA programmes that reduce administrative burden and cost while covering a broad test menu across multiple disciplines
MMQCI
Maine Molecular Quality Controls, Inc.
Maine Molecular Quality Controls, Inc. (MMQCI) is a privately held U.S. company that designs, develops, manufactures, and markets specialized molecular quality control products for clinical laboratories. Founded in 2000 and headquartered in Saco, Maine, MMQCI focuses on controls that monitor the accuracy of molecular tests for inherited diseases, oncology, infectious diseases, pharmacogenetics, and next‑generation sequencing (NGS) panels.
As experts in quality assurance of laboratory medicine, MMQCI produces high‑caliber controls intended to cover all phases of molecular testing, helping laboratories meet best‑practice and regulatory requirements while increasing confidence in patient results. The company operates an ISO 13485–type manufacturing environment and also supplies custom control solutions for in vitro diagnostic manufacturers, supporting emerging nucleic acid technologies and new molecular assay platforms.
COBIOER
Cobioer (Nanjing Cobioer Biotechnology Co., Ltd.)
Cobioer (Nanjing Cobioer Biotechnology Co., Ltd.) is a Chinese life science company that provides research-use-only biological products and outsourced biomedical research services for academia, hospitals, and the biopharmaceutical industry. The company’s portfolio includes research cell lines, diagnostic raw materials and standards (such as tumor, pathogen, and genetic reference materials), as well as technical services like stable cell line construction, viral packaging, molecular biology and gene editing support.
Positioning itself as a comprehensive platform, Cobioer focuses on early tumor diagnosis–related standards and tumor driver gene R&D services, alongside broader in vitro diagnostic material development. It has been recognized locally as a high-growth “gazelle” enterprise and reports certification to dual quality management systems (ISO 13485 and ISO 9001) for the development and sale of IVD raw materials and quality controls.
QCMD
QCMD (Quality Control for Molecular Diagnostics)
QCMD (Quality Control for Molecular Diagnostics) is an independent, not‑for‑profit international organisation that provides external quality assessment (EQA) and proficiency testing schemes focused on molecular infectious disease diagnostics. It offers a wide range of EQA programmes that supply laboratories with samples mimicking clinical specimens, allowing them to assess assay sensitivity, specificity, and overall performance using their routine molecular methods.
Headquartered in Glasgow and founded in 2001, QCMD has grown into one of the leading molecular EQA providers, with participation from thousands of laboratories in more than 100–120 countries worldwide. Its schemes are accredited to ISO 17043 and are designed to support laboratories in meeting regulatory and accreditation requirements such as ISO 15189, while also providing educational feedback to drive continuous quality improvement.